A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
Clinical trial NCT05473910 · RECRUITING
Trial details
- NCT number
- NCT05473910
- Sponsor
- TScan Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2026-06-01
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.